Keros Therapeutics Inc <KROS.O>: Leerink Partners cuts target price to $23 from $30
KROS•Related News
Brennan Investment Group acquires two industrial outdoor storage properties in Austin, Texas
XLRE•
Copper's Congo panic says more about copper than Congo: Andy Home
XLB•
Tuniu schedules second-quarter earnings release and conference call
TOUR•
Boston Fed's Collins open to interest rate increase in September, FT says
SPY•
Gold rebounds towards 10-week high as markets brace for US CPI data
GLD•